Yonghe Medical Group Co., Ltd. (02279) disclosed its Monthly Return for Equity Issuer for the month ended 28 February 2026. The total authorized share capital remained US$50,000, represented by 20,000,000,000 ordinary shares with a par value of US$0.0000025 per share.

The number of issued shares (excluding treasury shares) remained at 525.22 million, while treasury shares remained at 0.25 million, maintaining the total issued share count at 525.47 million. The company confirmed compliance with the applicable 25% public float requirement. No share options, warrants, convertible securities, or other arrangements to issue shares were noted during the period.